Ray Zhu
Founder & CEO
About AvanSight
Streamline the journey for groundbreaking drugs and devices
We specialize in a blend of consulting services and technological solutions tailored for biopharmaceutical companies and regulatory bodies such as the FDA.
Our mission
At the forefront of clinical trial consulting
At the heart of our offering is a clinical trial decision-support platform that empowers industry and government scientists with the tools they need to make informed decisions, both in designing clinical trials and in evaluating their outcomes.
With AvanSight, advancing medical innovation becomes a more efficient, clear-cut process.
Our history
Built to be a different kind of CRO
Established in 2020, our journey began with a vision to redefine industry standards by delivering unparalleled service to organizations of all sizes, across every trial phase. Disenchanted with the transactional approach and the often subpar quality of existing CROs, we set out to create a paradigm shift.
Our philosophy centers on a culture of excellence, robust partnership, and a shared commitment to clinical success. We are more than a CRO. We are your strategic ally in bringing groundbreaking therapies to market.
Meet our team
Leadership
Our comprehensive suite of professionals spans seasoned clinical architects and renowned engineers.
Roger Zhang
CTO
Philip Chen
CCO
Lynn Lin
CFO
Let us chat
Where we can help right now
- Trial design consultation
- Statistical data review
- Regulatory submission reporting and support